Drug Rehab Digital Marketing to Grow Admissions

The 2025 Reset: Why Admissions Growth Is Now a Trust Problem

In January 2025, the Federal Trade Commission sued Evoke Wellness and its executives, alleging the operator ran at least 68,510 misleading Google search ads that impersonated rival treatment providers and routed at least 3,500 calls to its own admissions center ¹. This complaint targeted paid search itself, a channel many treatment centers rely on to fill beds.

This case signals that admissions growth has shifted from a media-buying contest to a trust contest. The Opioid Addiction Recovery Fraud Prevention Act of 2018 already authorizes civil penalties for deceptive acts involving substance use disorder treatment services, and the FTC is now enforcing it ². Additionally, HHS guidance requires written authorization before protected health information is used for most marketing purposes, impacting landing pages, CRM syncs, and retargeting pixels that many programs still use routinely ³.

For a CMO, this means every channel now carries a compliance premium. Paid search bidding strategies, call-routing scripts, intake disclosures, and analytics tags are all subject to enforcement. Programs that built admissions on aggressive ad copy and loose attribution will spend the next year mitigating risk. Those built on evidence-based content, documented intake practices, and clean data flows will continue to grow. Growth in 2025 will favor operators who can defend how each admission was acquired, not just the quantity.

A Three-Layer Model for Admissions Growth

Compliance and Channel Risk After Evoke

The Evoke complaint highlighted the significant legal exposure associated with paid search. The Opioid Addiction Recovery Fraud Prevention Act of 2018 allows for civil penalties for unfair or deceptive acts in substance use disorder treatment services, and the FTC has shown it will pursue these against operators whose ad copy, call routing, or admissions scripts misrepresent affiliation or services ². This risk extends beyond obvious impersonation to brand-bidding tactics, vague level-of-care claims, and call-center openers that imply relationships with other providers.

HIPAA introduces parallel requirements. HHS guidance mandates written authorization for most marketing uses or disclosures of protected health information, with limited exceptions that often don’t cover common digital data flows ³. Practical failure points include:

• pixels on verification-of-benefits forms
• CRM fields syncing to ad platform customer-match audiences
• retargeting lists built from intake page visits

Patients also have the right to inquire about how their health information is used for marketing and to request restrictions, meaning consent language and data-handling practices must withstand patient scrutiny, not just internal audits ⁴.

The historical context for this regulatory stance includes documented patient brokering, lead-purchase schemes, and per-head marketer contracts, which several states have moved to ban ²¹. Peer-reviewed literature confirms that financial inducements distort clinical decisions and erode public trust ¹³. CMOs inheriting vendor contracts from older norms should integrate contract review, pixel inventory, and ad-copy substantiation as a single project. The defensible position post-Evoke is a documented chain from keyword to claim to call disclosure, readily reviewable.

Telehealth as an Acquisition and Retention Lever

Telehealth has evolved from a pandemic solution to a permanent entry point. SAMHSA reported that the share of substance use treatment facilities offering telemedicine more than doubled from 27.5% in 2019 to 58.6% in 2020 ⁶. This shift significantly impacts acquisition strategy by changing patient expectations. A program unable to offer virtual assessments, inductions, or continuation visits now competes against those that can, for the same search queries and insurance plans.

Telehealth’s value in the marketing budget is particularly evident in retention. NIDA-linked research indicates that initiating buprenorphine via telehealth is associated with a higher likelihood of longer treatment retention ⁷. The CDC highlights medications for opioid use disorder as a primary tool for maintaining treatment engagement and reducing overdose risk, with telehealth integrated into outpatient counseling pathways ⁸. In marketing terms, a telehealth-supported entry point extends the lifetime value of an admission, justifying a higher cost for the click that generated it.

However, messaging must align with delivery capabilities. Promising same-day virtual intake on a landing page is only effective if the schedule, licensed clinicians, and e-prescribing workflow are actually in place across targeted states. CMOs aiming to leverage telehealth for both acquisition and retention should confirm:

• state licensure for virtual care
• realistic time-to-first-clinical-contact (during and after hours)
• platform support for continuation visits that drive retention

Without these, telehealth claims risk becoming unsubstantiated, a target for FTC scrutiny.

Intake Call Handling and the Qualified-Admission Economics Frame

The Health Affairs audit-call study on U.S. residential opioid use disorder programs found that one-third of callers were offered admission before any clinical evaluation, often within a single day, and that for-profit programs charged more than twice the upfront cost of nonprofit programs ¹². These findings highlight critical intersections between marketing and clinical care. An admission offered pre-assessment may later need to be reversed, and significant price disparities influence which callers convert and which disengage.

To address these issues, lead volume should be replaced as the primary intake metric by three measurable operator variables linked to spend:

• Qualified VOB rate. This is the percentage of inbound calls resulting in a workable verification of benefits within a defined timeframe. “Workable” implies in-network or single-case-agreement viability, geographic licensure, and a level-of-care match for the program. This metric assesses whether marketing is generating appropriate calls, not just calls.
• Admission rate. This is the percentage of qualified VOBs that convert to a clinical admission after assessment, not before. Requiring a clinical screening gate distinguishes a defensible intake operation from the pattern observed in the audit-call study ¹². Programs that guide callers through a brief structured assessment and provide named referrals when there’s a poor fit protect both outcomes and reputation ⁹.
• Cost per admission. This is the total channel spend divided by clinical admissions, segmented by campaign and substance profile. This metric provides a consistent basis for comparing the effectiveness of paid search, content, and referral programs.

The proactive-engagement literature also emphasizes tracking the time from the first call to the first clinical contact, including reminder outreach and barrier reduction ¹⁰. Programs that shorten this interval without compromising assessment tend to retain more admitted patients, which ultimately makes the initial click profitable.

Audience Segmentation: Self-Seekers, Parents, and Young Adults

Most rehabilitation campaigns target a single audience: adults with a substance use disorder in crisis. While this audience exists, it is not the only one, and neglecting other segments leaves significant demand untapped.

Parent-directed campaigns are a clear example. Research on marketing therapy for adolescent substance use suggests that parent-focused strategies can increase therapy uptake among adolescents at risk ¹⁵. Keywords, creative content, and conversion paths differ significantly when the searcher is a parent concerned about their child. Search terms shift to warning signs, school performance, and communication strategies for teenagers. Landing pages need to address parental concerns about confidentiality, family involvement, and the clinical assessment process. The resulting call is typically a consultation, not a self-admission, potentially leading to an adolescent intake weeks later.

Young adults represent a distinct segment, not merely a younger version of the adult funnel. Clinical literature on evidence-based treatment for young adults highlights their unique engagement needs and treatment responses ¹⁶. Messaging effective for a 45-year-old executive seeking residential alcohol treatment will not resonate with a 22-year-old whose primary substance is cannabis or stimulants, and whose decisions are influenced by peers, school, or a first job. Specialized therapies exist for various substance use disorders, and creative content should explicitly name the substance and modality offered, rather than using generic recovery language ¹⁷. Segmenting by age, substance, and decision-maker allows a CMO to transform a single media budget into multiple campaigns, each converting effectively for its specific audience.

Measurement: Qualified VOBs, Admission Rate, and 30/90-Day Retention

The reporting layer is often where growth strategies falter. A CMO presenting monthly lead counts and cost per lead to a board will struggle to explain stagnant census numbers. The solution is to replace funnel-top metrics with three numbers that link spend to clinical outcomes, tracked by campaign, substance profile, and referral source, rather than as a single aggregated figure.

The first metric is the qualified VOB rate, which measures the proportion of calls a channel generates that can realistically become admissions, based on in-network or single-case-agreement viability, state licensure, and a matching level of care. The second is the admission rate, calculated against qualified VOBs and contingent on a structured clinical assessment, not a same-day bed offer. Maintaining this clinical screening gate differentiates a defensible operation from the pattern documented in the Health Affairs audit-call study, where one-third of callers were offered admission before any clinical evaluation ¹². The third metric, cost per admission, provides the only honest basis for comparing paid search, content, and referral programs.

Retention should also be on the dashboard. The CDC identifies medications for opioid use disorder as a key factor in maintaining treatment and reducing overdose risk ⁸, and clinical literature links proactive follow-up and barrier reduction to longer engagement ¹⁰. Reporting 30-day and 90-day retention by acquisition channel completes the picture.

If You Manage Multiple Locations: Portfolio Allocation Notes

This section is for operators managing two or more facilities under a single P&L; single-site CMOs may skip ahead. Portfolio allocation introduces complexities rarely faced by single-site teams, such as state licensure mismatches, cross-facility referral leakage, and the temptation to concentrate spending on the fastest-ranking location.

Three variables typically govern allocation:

1. Qualified-call density by geography. SAMHSA’s TEDS data shows admissions vary unevenly by state and primary substance, meaning national keyword bidding often overpays in markets where a program lacks licensed levels of care ¹⁸.
2. Telehealth state coverage. Programs that expanded virtual entry points after 2020 can accommodate out-of-state demand that brick-and-mortar locations cannot, altering the profitability of paid search ⁶.
3. Intake routing integrity. Cross-facility transfers without documented clinical reasons resemble patient-brokering practices flagged by congressional staff, even within the same corporate entity ²¹.

The portfolio CMO’s role is to allocate resources based on qualified VOB yield per facility, rather than simply by which location has open beds. The latter approach risks reintroducing the lead-volume mindset this framework aims to eliminate.

What Strong Programs Will Do in the Next 12 Months

Operators who achieve growth through 2025 will implement a specific set of actions. They will audit every paid search ad, landing page claim, and call-center opener against the substantiation standard applied in the Evoke Wellness case, removing any copy that fails this review ¹. They will inventory pixels, CRM syncs, and retargeting audiences against HHS marketing guidance, then reconstruct consent flows to prevent patient inquiries from escalating into enforcement issues ³.

They will replace lead-volume dashboards with metrics like qualified VOB rate, admission rate (gated by clinical assessment), and 30/90-day retention by channel. Telehealth state coverage will be treated as a media-planning input, not a clinical footnote ⁶. Furthermore, admissions coordinators will be briefed on the campaigns that generated each call, ensuring the initial interaction aligns with the caller’s search intent. Programs that adopt these practices will spend less per admission and be able to defend every admission they secure.